Contract Details
- Signed on November 2, 2026, by Hikal's Crop Protection division
- Multi-year contract for supply of a specialized agrochemical product to markets worldwide
- Contract covers CDMO services for a product for which Hikal undertook process development and scale-up
- Counterparty is a Europe-based global agrochemical company (name not disclosed)
Timeline and Commercialization
- Commercial launch expected towards the end of FY 2026-27
- Volumes anticipated to grow progressively as regulatory approvals are secured across global markets
- The contract converts nearly three years of collaborative development and scale-up work
Business Impact and Significance
- Marks a key commercial milestone for Hikal's Crop Protection business
- Strengthens Hikal's Crop Protection business by expanding its portfolio of specialized offerings
- Demonstrates Hikal's capabilities in process development and commercialization
- Underscores ability to translate customer requirements into long-term manufacturing opportunities
- Shows technical expertise in combining deep technical expertise with reliable manufacturing capabilities
Company Background
Hikal Limited partners with global companies across pharmaceuticals, crop protection, animal health and specialty chemicals. The company leverages its research and development, process chemistry and manufacturing capabilities to support customers from development through commercial production. Hikal has five manufacturing facilities in India at Maharashtra (Taloja and Mahad), Gujarat (Panoli) and Bengaluru (Jigani) and a world-class Research & Technology centre at Pune.
Regulatory Filing
- Filed with BSE Limited (Scrip Code: 524735) and National Stock Exchange of India Limited (Symbol: HIKAL)
- Signed by Rajasekhar Reddy Chintakindi, Company Secretary & Compliance Officer
- Dated November 2, 2026